Background illustration for clinical trials search

Paid Clinical Trials Akron

Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

for
Solid Tumor, MET Alteration
Location: Canton OH, Washington D.C. DC, Nashville TN
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT06669117

Phase 1, Phase 2, Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer,
Location: Canton OH, Detroit MI, Fairfax VA, Durham NC,
Sponsor: Sairopa B.V.

Sex: All

Age: 18+

Code: NCT05856981

Phase 1, Recruiting

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

for
Non-small Cell Lung Cancer
Location: Canton OH, Cleveland OH, Mayfield Heights OH,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06712316

Phase 2, Phase 3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Canton OH, Strongsville OH, Independence OH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis

for
Primary Myelofibrosis (PMF),
Location: Canton OH, Houston TX, Glendale CA, Whittier CA
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04878003

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

for
Advanced Melanoma
Location: Canton OH, Pittsburgh PA, Toronto, Bethesda MD,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT06697301

Phase 2, Phase 3, Recruiting

Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies

for
B-Cell Malignancies
Location: Canton OH
Sponsor: TransThera Sciences (Nanjing), Inc.

Sex: All

Age: 18+

Code: NCT05275504

Phase 1, Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Canton OH, Maumee OH, Grand Rapids MI, York PA,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment

for
Primary Myelofibrosis (PMF),
Location: Canton OH, Chicago IL, Milwaukee WI, New York NY,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT03662126

Phase 2, Phase 3, Recruiting

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

for
Lung Cancer, Non-small Cell, Lung Cancer Metastatic,
Location: Canton OH, Cleveland OH, Detroit MI, Nasville TN,
Sponsor: Krystal Biotech, Inc.

Sex: All

Age: 18+

Code: NCT06228326

Phase 1, Phase 2, Recruiting

XTX301 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Canton OH, Cleveland OH, Pittsburgh PA, Columbus OH,
Sponsor: Xilio Development, Inc.

Sex: All

Age: 18+

Code: NCT05684965

Phase 1, Phase 2, Recruiting

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

for
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations,
Location: Canton OH, Brampton, Fairfax VA, Milwaukee WI,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05967689

Phase 2, Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Canton OH, Pittsburgh PA, Columbus OH, Fairfax VA,
Sponsor: OncoNano Medicine, Inc.

Sex: All

Age: 18+

Code: NCT06022029

Phase 1, Recruiting

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

for
Triple Negative Breast Cancer
Location: Canton OH, Columbus GA, Springfield MO
Sponsor: Jina Pharmaceuticals Inc.

Sex: Female

Age: 18 - 65

Code: NCT03671044

Phase 3, Recruiting

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

for
Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer
Location: Canton OH, Detroit MI, Boston MA
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT03797391

Phase 1, Phase 2, Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Canton OH, Cleveland OH, Pittsburgh PA, Detroit MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase 3, Recruiting

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

for
Metastatic Pancreatic Adenocarcinoma
Location: Canton OH, Tampa FL, Whittier CA
Sponsor: Eleison Pharmaceuticals LLC.

Sex: All

Age: 18+

Code: NCT01954992

Phase 3, Recruiting

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

for
Lung Cancer, Adjuvant, Post-surgical, EGFR, Exon 20,
Location: Canton OH, Dearborn MI, Toronto, Fairfax VA,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07128199

Phase 3, Recruiting

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

for
Oropharyngeal Carcinoma (OPC)
Location: Canton OH, Omaha NE, Orlando FL
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT07768189

Phase 3, Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Canton OH, Cleveland OH, Pittsburgh PA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase 3, Recruiting